| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'12 | Dec'11 | |
|---|---|---|---|---|---|---|
Net loss | ||||||
-5,193 | -4,770 | -11,731 | -72 | -1,208 | 237 | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
3,074 | 3,147 | 3,897 | 6 | - | - | |
Gain on sale of discontinued operations | ||||||
- | - | -2,340 | 0 | - | - | |
Gain on change in warrant liability | ||||||
-288 | 193 | -1,351 | - | - | - | |
Loss from disposal of fixed assets - net of accumulated depreciation | ||||||
-76 | - | - | - | - | - | |
Gain on change in warrant liability | ||||||
- | - | - | -0 | - | - | |
Impairment of intangible assets and goodwill | ||||||
- | - | - | 51 | - | - | |
Impairment of long-lived assets | ||||||
- | - | 209 | 0 | - | - | |
Stock-based compensation | ||||||
447 | 904 | 1,563 | 2 | - | - | |
Non-cash treasury stock | ||||||
- | - | - | -0 | - | - | |
Non-cash loan origination fees | ||||||
75 | 72 | 756 | 0 | - | - | |
Non-cash consulting expense | ||||||
- | - | 320 | 0 | - | - | |
Non-cash directors' fees | ||||||
- | - | 31 | 0 | - | - | |
Inventory reserve adjustment for obsolescence | ||||||
44 | 60 | - | - | - | - | |
Allowance for doubtful accounts | ||||||
-19 | 93 | - | - | - | - | |
Allowance for doubtful accounts | ||||||
- | - | 408 | 0 | - | - | |
Deferred tax (benefit) | ||||||
- | -18 | 25 | - | - | - | |
Changes in operating assets and liabilities: | ||||||
Deferred tax expense | ||||||
- | - | - | -6 | - | - | |
Accounts receivable | ||||||
419 | 518 | 2,281 | -7 | - | - | |
Inventory | ||||||
-37 | -127 | 392 | -3 | - | - | |
Other current assets | ||||||
194 | -334 | 129 | -1 | - | - | |
Non-current deferred tax liabilities | ||||||
- | -5 | - | - | - | - | |
Other assets | ||||||
-45 | -3 | -294 | 0 | - | - | |
Accounts payable | ||||||
-747 | 268 | -1,280 | -1 | - | - | |
Change in fair value of warrant liability | ||||||
- | - | - | - | 600 | 600 | |
(Increase) in accrued interest income | ||||||
- | - | - | - | 37 | -37 | |
(Increase) decrease in prepaid expenses | ||||||
- | - | - | - | -15 | 18 | |
Accrued liabilities | ||||||
-999 | -739 | -823 | -0 | 1,158 | 176 | |
Deferred revenue | ||||||
596 | -685 | 141 | -0 | - | - | |
Loss (gain) on long-term contract | ||||||
- | 616 | - | - | - | - | |
Gain on long-term contract | ||||||
- | - | -3,068 | -3 | - | - | |
Deferred rent and other liabilities | ||||||
-215 | -272 | -708 | -0 | - | - | |
Net cash used in operating activities | ||||||
-3,680 | -2,422 | -11,443 | -8 | -597 | -242 | |
Cash flows from investing activities | ||||||
Proceeds from sale of discontinued operations | ||||||
- | - | 1,190 | - | - | - | |
Proceeds from sale of discontinued operations | ||||||
- | - | - | 0 | - | - | |
Purchases of property and equipment | ||||||
120 | 348 | 381 | 2 | - | - | |
Net cash used in investing activities | ||||||
-120 | -348 | 809 | -2 | - | - | |
Cash flows from financing activities | ||||||
Borrowings on secured line of credit | ||||||
1,250 | 3,500 | 400 | 0 | - | - | |
Payments on secured line of credit | ||||||
1,274 | 2,626 | - | - | - | - | |
Proceeds from bridge loan | ||||||
- | - | 1,000 | 6 | - | - | |
Debt issuance costs | ||||||
60 | 15 | 137 | 0 | - | - | |
Conversion of preferred to common stock | ||||||
- | - | 41 | 0 | - | - | |
Issuance of common stock, net of issuance costs | ||||||
- | 4,370 | - | - | - | - | |
Issuance of preferred stock, net of issuance costs | ||||||
- | - | 9,627 | - | - | - | |
Issuance of preferred shares, net of issuance costs | ||||||
- | - | - | 0 | - | - | |
Investments held in Trust Account | ||||||
- | - | - | - | 0 | 80,000 | |
Proceeds from public offering, net of underwriting discount | ||||||
- | - | - | - | - | 78,000 | |
Proceeds from issuance of warrants | ||||||
- | - | - | - | - | 3,000 | |
Proceeds from notes payable, Sponsor | ||||||
- | - | - | - | 460 | 175 | |
Proceeds from notes payable, Chief Executive Officer | ||||||
- | - | - | - | 200 | - | |
Proceeds from issuance of stock to initial investor | ||||||
- | - | - | - | - | 25 | |
Payment of note payable, Sponsor | ||||||
- | - | - | - | - | 175 | |
Expenses related to sale of stock | ||||||
- | - | - | - | - | 433 | |
Net cash provided by (used in) financing activities | ||||||
-84 | 5,229 | 10,849 | 6 | 660 | 80,591 | |
Effect of exchange rate changes on cash | ||||||
280 | -523 | -86 | -0 | - | - | |
Net increase in cash and cash equivalents | ||||||
-3,604 | 1,936 | 129 | -5 | - | - | |
Supplemental disclosures of cash flow information: | ||||||
Cash paid during the year for interest | ||||||
199 | 158 | - | - | - | - | |
Cash paid during the period for interest | ||||||
- | - | 689 | 1 | - | - | |
Cash paid during the period for income taxes | ||||||
356 | 386 | 275 | 0 | - | - | |
Leasehold improvements acquired through landlord allowance | ||||||
- | - | - | 1 | - | - | |
Issuance of common stock for warrants | ||||||
- | - | - | 2 | - | - | |
Net increase (decrease) in cash | ||||||
- | - | - | - | 62 | 348 | |
Deferred underwriter's fee | ||||||
- | - | - | - | 0 | 2,000 | |
Notes payable transferred to Chief Executive Officer | ||||||
- | - | - | - | 200 | 0 | |
Deferred underwriter's fee | ||||||
- | - | - | - | 0 | 2,000 | |
Adjustment for warrant liability in connection with the public offering | ||||||
- | - | - | - | 0 | 4,200 | |